marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 10-19-2024
CollPlant Biotechnologies Ltd. Balance Sheet 2011-2024 | CLGN
Annual Balance Sheet CollPlant Biotechnologies Ltd.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -5.64 M | -1.49 M | -987 K | -1.36 M | -2.84 M | -6.83 M | - | - | ||
Long Term Debt |
- | - | - | - | - | 22.3 K | 3.64 M | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | 440 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
2.54 M | 2.38 M | 3.09 M | 2.98 M | 3.21 M | 2.05 M | 4.04 M | 641 K | - | - | - | - | - |
Total Current Liabilities |
3.25 M | 3.1 M | 3.01 M | 3.39 M | 3.46 M | - | - | - | - | - | - | - | - |
Total Liabilities |
5.79 M | 5.49 M | 6.1 M | 6.36 M | 6.66 M | 4.29 M | 5.46 M | 2.41 M | 961 K | 680 K | 916 K | - | - |
Deferred Revenue |
- | - | - | 207 K | 942 K | 965 K | - | - | - | - | - | - | - |
Retained Earnings |
-96.7 M | -89.7 M | -72.8 M | -73 M | -67.3 M | -49 M | -50.2 M | -41.1 M | -34.2 M | -30.6 M | -30.5 M | - | - |
Total Assets |
34.1 M | 37.8 M | 51.2 M | 10.8 M | 10.8 M | 9.05 M | 8.07 M | 3.75 M | 3.47 M | 4.35 M | 8.69 M | - | - |
Cash and Cash Equivalents |
- | - | - | 3.33 M | 3.79 M | 5.66 M | - | - | - | - | - | - | - |
Book Value |
28.3 M | 32.3 M | 45.1 M | 4.48 M | 4.09 M | 4.76 M | 2.61 M | 1.34 M | 2.51 M | 3.68 M | 7.78 M | - | - |
Total Shareholders Equity |
28.3 M | 32.3 M | 45.1 M | 4.48 M | 4.09 M | 5.42 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet CollPlant Biotechnologies Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 30 K | - | 2.65 M | - | 11 K | - | 2.95 M | - | 63 K | - | - | - | - | - | - | - | 2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 3.09 M | - | 2.65 M | - | 2.98 M | - | 3 M | - | 3.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 6.1 M | - | 5.58 M | - | 6.36 M | - | 5.17 M | - | 6.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | 32 K | - | - | - | 207 K | - | 297 K | - | 942 K | - | - | - | 970 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -72.8 M | - | -65.9 M | - | -73 M | - | -70.8 M | - | -67.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 51.2 M | - | 55 M | - | 10.8 M | - | 10.9 M | - | 10.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 13.1 M | - | 17.5 M | - | 3.33 M | - | 3.67 M | - | 3.79 M | - | 1.91 M | - | 5.35 M | - | - | - | 5.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 45.1 M | - | 49.4 M | - | 4.48 M | - | 5.78 M | - | 4.09 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 45.1 M | - | 49.4 M | 50.6 M | 4.48 M | - | 5.78 M | 7.27 M | 4.09 M | - | 764 K | 1.72 M | 5.42 M | - | - | - | 5.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency